
Anna Kathy Aman
Examiner (ID: 18092, Phone: (571)272-4515 , Office: P/2914 )
| Most Active Art Unit | 2914 |
| Art Unit(s) | 2914, 2973 |
| Total Applications | 3318 |
| Issued Applications | 3249 |
| Pending Applications | 17 |
| Abandoned Applications | 54 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6598383
[patent_doc_number] => 20100048703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-25
[patent_title] => 'Hair care product'
[patent_app_type] => utility
[patent_app_number] => 12/585674
[patent_app_country] => US
[patent_app_date] => 2009-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7643
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20100048703.pdf
[firstpage_image] =>[orig_patent_app_number] => 12585674
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/585674 | Hair care product | Sep 21, 2009 | Issued |
Array
(
[id] => 6495080
[patent_doc_number] => 20100009984
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-14
[patent_title] => 'AEROSOL FORMULATIONS FOR THE INHALATION OF BETA-AGONISTS'
[patent_app_type] => utility
[patent_app_number] => 12/564477
[patent_app_country] => US
[patent_app_date] => 2009-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11690
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20100009984.pdf
[firstpage_image] =>[orig_patent_app_number] => 12564477
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/564477 | AEROSOL FORMULATIONS FOR THE INHALATION OF BETA-AGONISTS | Sep 21, 2009 | Abandoned |
Array
(
[id] => 4629443
[patent_doc_number] => 08008330
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-30
[patent_title] => 'Combinations comprising epothilones and pharmaceutical uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/549947
[patent_app_country] => US
[patent_app_date] => 2009-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6480
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/008/08008330.pdf
[firstpage_image] =>[orig_patent_app_number] => 12549947
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/549947 | Combinations comprising epothilones and pharmaceutical uses thereof | Aug 27, 2009 | Issued |
Array
(
[id] => 7527458
[patent_doc_number] => 08044050
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-10-25
[patent_title] => 'Imidazo[1,2-a]azines and their use as pharmaceuticals'
[patent_app_type] => utility
[patent_app_number] => 12/548641
[patent_app_country] => US
[patent_app_date] => 2009-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15264
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/044/08044050.pdf
[firstpage_image] =>[orig_patent_app_number] => 12548641
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/548641 | Imidazo[1,2-a]azines and their use as pharmaceuticals | Aug 26, 2009 | Issued |
Array
(
[id] => 4609548
[patent_doc_number] => 07994197
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-09
[patent_title] => 'Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile'
[patent_app_type] => utility
[patent_app_number] => 12/548292
[patent_app_country] => US
[patent_app_date] => 2009-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9904
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/994/07994197.pdf
[firstpage_image] =>[orig_patent_app_number] => 12548292
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/548292 | Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile | Aug 25, 2009 | Issued |
Array
(
[id] => 8214402
[patent_doc_number] => 08193220
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2012-06-05
[patent_title] => 'Method of changing muscle lengths with anesthetic drugs'
[patent_app_type] => utility
[patent_app_number] => 12/583424
[patent_app_country] => US
[patent_app_date] => 2009-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4530
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/193/08193220.pdf
[firstpage_image] =>[orig_patent_app_number] => 12583424
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/583424 | Method of changing muscle lengths with anesthetic drugs | Aug 19, 2009 | Issued |
Array
(
[id] => 6249221
[patent_doc_number] => 20100137330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-03
[patent_title] => 'Use'
[patent_app_type] => utility
[patent_app_number] => 12/539858
[patent_app_country] => US
[patent_app_date] => 2009-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4906
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20100137330.pdf
[firstpage_image] =>[orig_patent_app_number] => 12539858
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/539858 | Use | Aug 11, 2009 | Abandoned |
Array
(
[id] => 4470565
[patent_doc_number] => 07943664
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-05-17
[patent_title] => 'Phosphate binding materials and their uses'
[patent_app_type] => utility
[patent_app_number] => 12/536014
[patent_app_country] => US
[patent_app_date] => 2009-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 19
[patent_no_of_words] => 10851
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/943/07943664.pdf
[firstpage_image] =>[orig_patent_app_number] => 12536014
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/536014 | Phosphate binding materials and their uses | Aug 4, 2009 | Issued |
Array
(
[id] => 4451260
[patent_doc_number] => 07964584
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-06-21
[patent_title] => 'Method of treating or preventing osteoporosis comprising administering to a patient in need thereof an effective amount of pharmaceutical composition comprising benzamidine derivatives or their salts, and alendronic acid or its salt'
[patent_app_type] => utility
[patent_app_number] => 12/533537
[patent_app_country] => US
[patent_app_date] => 2009-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5152
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/964/07964584.pdf
[firstpage_image] =>[orig_patent_app_number] => 12533537
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/533537 | Method of treating or preventing osteoporosis comprising administering to a patient in need thereof an effective amount of pharmaceutical composition comprising benzamidine derivatives or their salts, and alendronic acid or its salt | Jul 30, 2009 | Issued |
Array
(
[id] => 6102641
[patent_doc_number] => 20110166134
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-07
[patent_title] => 'Glucosylceramide Synthase Inhibition For The Treatment Of Collapsing Glomerulopathy And Other Glomerular Disease'
[patent_app_type] => utility
[patent_app_number] => 13/055036
[patent_app_country] => US
[patent_app_date] => 2009-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 46613
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20110166134.pdf
[firstpage_image] =>[orig_patent_app_number] => 13055036
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/055036 | Glucosylceramide synthase inhibition for the treatment of collapsing glomerulopathy and other glomerular disease | Jul 26, 2009 | Issued |
Array
(
[id] => 8257722
[patent_doc_number] => 08207199
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-26
[patent_title] => 'Azole compound'
[patent_app_type] => utility
[patent_app_number] => 13/054057
[patent_app_country] => US
[patent_app_date] => 2009-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14874
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13054057
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/054057 | Azole compound | Jul 12, 2009 | Issued |
Array
(
[id] => 5558924
[patent_doc_number] => 20090270501
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-29
[patent_title] => 'COMPOSITION AND METHOD FOR INCREASING THE ANABOLIC STATE OF MUSCLE CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/499109
[patent_app_country] => US
[patent_app_date] => 2009-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4074
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20090270501.pdf
[firstpage_image] =>[orig_patent_app_number] => 12499109
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/499109 | Composition and method for increasing the anabolic state of muscle cells | Jul 7, 2009 | Issued |
Array
(
[id] => 8232850
[patent_doc_number] => 08198292
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-12
[patent_title] => 'Vinpocetine and eburnamonine derivatives for promoting bone growth, treating renal damage and cancer, and devices thereof'
[patent_app_type] => utility
[patent_app_number] => 12/494670
[patent_app_country] => US
[patent_app_date] => 2009-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 12787
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/198/08198292.pdf
[firstpage_image] =>[orig_patent_app_number] => 12494670
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/494670 | Vinpocetine and eburnamonine derivatives for promoting bone growth, treating renal damage and cancer, and devices thereof | Jun 29, 2009 | Issued |
Array
(
[id] => 6249242
[patent_doc_number] => 20100137348
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-03
[patent_title] => 'PHARMACEUTICAL FORMULATIONS: SALTS OF 8-[-METHYL]-8-PHENYL-1,7-DIAZA-SPIRO[4.5]DECAN-2-ONE AND TREATMENT METHODS USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/487263
[patent_app_country] => US
[patent_app_date] => 2009-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5625
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20100137348.pdf
[firstpage_image] =>[orig_patent_app_number] => 12487263
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/487263 | Pharmaceutical formulations: salts of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-Ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same | Jun 17, 2009 | Issued |
Array
(
[id] => 5458767
[patent_doc_number] => 20090258919
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-15
[patent_title] => 'Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and / or congestive heart failure'
[patent_app_type] => utility
[patent_app_number] => 12/457589
[patent_app_country] => US
[patent_app_date] => 2009-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3095
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20090258919.pdf
[firstpage_image] =>[orig_patent_app_number] => 12457589
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/457589 | Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and / or congestive heart failure | Jun 15, 2009 | Abandoned |
Array
(
[id] => 7988125
[patent_doc_number] => 08076357
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-12-13
[patent_title] => 'Compositions of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide'
[patent_app_type] => utility
[patent_app_number] => 12/471950
[patent_app_country] => US
[patent_app_date] => 2009-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8032
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/076/08076357.pdf
[firstpage_image] =>[orig_patent_app_number] => 12471950
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/471950 | Compositions of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide | May 25, 2009 | Issued |
Array
(
[id] => 112007
[patent_doc_number] => 07718643
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-18
[patent_title] => 'Pharmaceutical formulation'
[patent_app_type] => utility
[patent_app_number] => 12/472021
[patent_app_country] => US
[patent_app_date] => 2009-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5356
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/718/07718643.pdf
[firstpage_image] =>[orig_patent_app_number] => 12472021
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/472021 | Pharmaceutical formulation | May 25, 2009 | Issued |
Array
(
[id] => 7997455
[patent_doc_number] => 08080575
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-12-20
[patent_title] => 'Gamma-lactam compounds for promoting bone growth'
[patent_app_type] => utility
[patent_app_number] => 12/472134
[patent_app_country] => US
[patent_app_date] => 2009-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 11545
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/080/08080575.pdf
[firstpage_image] =>[orig_patent_app_number] => 12472134
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/472134 | Gamma-lactam compounds for promoting bone growth | May 25, 2009 | Issued |
Array
(
[id] => 9286204
[patent_doc_number] => 08642533
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-02-04
[patent_title] => 'Methods of nourishing animals'
[patent_app_type] => utility
[patent_app_number] => 12/993783
[patent_app_country] => US
[patent_app_date] => 2009-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 83
[patent_no_of_words] => 23829
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12993783
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/993783 | Methods of nourishing animals | May 21, 2009 | Issued |
Array
(
[id] => 8834578
[patent_doc_number] => 08450334
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-05-28
[patent_title] => 'Hepsin inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/997465
[patent_app_country] => US
[patent_app_date] => 2009-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 11
[patent_no_of_words] => 25173
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12997465
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/997465 | Hepsin inhibitors | May 20, 2009 | Issued |